Many women also report menstrual irregularities after starting GLP-1 treatment, a side effect that has been observed in recent studies exploring hormonal changes linked to GLP-1 medications
Kong FJ, Wu JH, Sun SY, Ma LL, Zhou JQ
Description Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide developed as a triple agonist at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Energy & Focus+ GLP-1 Contains Semaglutide, NAD+ and Vitamin B12 Compounded Semaglutide injection formulated with NAD+ and Vitamin B12 to help support balanced energy, focus, and metabolic performance
Our meals feature gentle ingredients and smaller portion sizes that help minimize digestive discomfort
If any other use is desired, permission in writing from Dr